PPARG and obesity due to melanocortin 4 receptor deficiency: In addition, PPARγ was increased significantly by 2.84-fold (p = 0.0041), suggesting the hypoglycemic mechanism of CB0313.1 may be associated with an attenuation of energy metabolic dysfunction and obesity (Fig. 4d and e).